Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery-Reference-Cited by-同舟云学术

Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery

Published:2021-03-27 Issue:3 Volume:27 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Pabinger Ingrid¹^ORCID,Mamonov Vasily²,Windyga Jerzy³^ORCID,Engl Werner⁴,Doralt Jennifer⁴,Tangada Srilatha⁵,Spotts Gerald⁵,Ewenstein Bruce⁵

Affiliation:

1. Medical University of Vienna Vienna Austria

2. National Research Center for Hematology Moscow Russia

3. Department of Disorders of Hemostasis and Internal Medicine Institute of Hematology and Transfusion Medicine Warsaw Poland

4. Baxalta Innovations GmbH, a Takeda company Vienna Austria

5. Baxalta US Inc., a Takeda company Cambridge Massachusetts USA

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14219

Reference24 articles.

1. ADVATE (antihemophilic factor [recombinant]) [summary of product characteristics];2013.http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/000520/WC500022467.pdf. Accessed August 20 2018

2. ADVATE (antihemophilic factor [recombinant]).Westlake Village CA:Baxalta US Inc;2016.

3. Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia A

4. The use of continuous infusion of factor concentrates in the treatment of hemophilia

5. Coagulation factor concentrates by continuous infusion

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology;Journal of Thrombosis and Haemostasis;2024-09

2. In the era of primary prophylaxis in hemophilia, what types of orthopedic surgical interventions have been published in the 2020–2023 period and in which countries?;Expert Review of Hematology;2023-11-19

3. Managing Relevant Clinical Conditions of Hemophilia A/B Patients;Hematology Reports;2023-06-07

4. Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery;Journal of Thrombosis and Thrombolysis;2022-12-22

5. How do we optimally utilize factor concentrates in persons with hemophilia?;Hematology;2021-12-10